Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 871657, 8 pages
http://dx.doi.org/10.1155/2014/871657
Research Article

Behavioral and Histopathological Study of Changes in Spinal Cord Injured Rats Supplemented with Spirulina platensis

Department of Anatomy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia

Received 16 May 2014; Accepted 2 July 2014; Published 24 July 2014

Academic Editor: Siew Hua Gan

Copyright © 2014 Izzuddin Aziz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. S. Sharma, “New perspectives for the treatment options in spinal cord injury,” Expert Opinion on Pharmacotherapy, vol. 9, no. 16, pp. 2773–2800, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. H. Sekhon and M. G. Fehlings, “Epidemiology, demographics, and pathophysiology of acute spinal cord injury,” Spine, vol. 26, no. 24, pp. S2–S12, 2001. View at Google Scholar · View at Scopus
  3. B. K. Kwon, E. B. Okon, W. Plunet et al., “A systematic review of directly applied biologic therapies for acute spinal cord injury,” Journal of Neurotrauma, vol. 28, no. 8, pp. 1589–1610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. H. Yoon, Y. S. Kim, and W. Young, “Therapeutic time window for methylprednisolone in spinal cord injured rat,” Yonsei Medical Journal, vol. 40, no. 4, pp. 313–320, 1999. View at Google Scholar · View at Scopus
  5. I. Koyanagi and C. H. Tator, “Effect of a single huge dose of methylprednisolone on blood flow, evoked potentials, and histology after acute spinal cord injury in the rat,” Neurological Research, vol. 19, no. 3, pp. 289–299, 1997. View at Google Scholar · View at Scopus
  6. D. J. Short, W. S. El Masry, and P. W. Jones, “High dose methylprednisolone in the management of acute spinal cord injury—a systematic review from a clinical perspective,” Spinal Cord, vol. 38, no. 5, pp. 273–286, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. F. T. Sayer, E. Kronvall, and O. G. Nilsson, “Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature,” Spine Journal, vol. 6, no. 3, pp. 335–343, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Galandiuk, G. Raque, S. Appel et al., “The two-edged sword of large-dose steroids for spinal cord trauma,” Annals of Surgery, vol. 218, no. 4, pp. 419–425, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Capelli and G. Cysewski, “Potential health benefits of spirulina microalgae,” Nutrafoods, vol. 9, no. 2, pp. 19–26, 2010. View at Google Scholar
  10. M. Careri, L. Furlattini, A. Mangia et al., “Supercritical fluid extraction for liquid chromatographic determination of carotenoids in Spirulina Pacifica algae: a chemometric approach,” Journal of Chromatography A, vol. 912, no. 1, pp. 61–71, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Gömör, “Selective inhibition of cyclooxygense (COX-2),” Orvosi Hetilap, vol. 140, no. 8, pp. 395–399, 1999. View at Google Scholar · View at Scopus
  12. G. V. Mitchell, E. Grundel, M. Jenkins, and S. R. Blakely, “Effects of graded dietary levels of spirulina maxima on vitamins A and E in male rats,” Journal of Nutrition, vol. 120, no. 10, pp. 1235–1240, 1990. View at Google Scholar · View at Scopus
  13. M. S. Miranda, R. G. Cintra, S. B. M. Barros, and J. Mancini-Filho, “Antioxidant activity of the microalga Spirulina maxima,” Brazilian Journal of Medical and Biological Research, vol. 31, no. 8, pp. 1075–1079, 1998. View at Google Scholar · View at Scopus
  14. K. Premkumar, A. Pachiappan, S. K. Abraham, S. T. Santhiya, P. M. Gopinath, and A. Ramesh, “Effect of Spirulina fusiformis on cyclophosphamide and mitomycin-C induced genotoxicity and oxidative stress in mice,” Fitoterapia, vol. 72, no. 8, pp. 906–911, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. C. D. Upasani, A. Khera, and R. Balaraman, “Effect of lead with vitamin E, C, or Spirulina on malondialdehyde, conjugated dienes and hydroperoxides in rats,” Indian Journal of Experimental Biology, vol. 39, no. 1, pp. 70–74, 2001. View at Google Scholar · View at Scopus
  16. B. Mathew, R. Sankaranarayanan, P. P. Nair et al., “Evaluation of chemoprevention of oral cancer with Spirulina fusiformis,” Nutrition and Cancer, vol. 24, no. 2, pp. 197–202, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Wang, C. Chang, J. Chou et al., “Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage,” Experimental Neurology, vol. 193, no. 1, pp. 75–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Thaakur and R. Sravanthi, “Neuroprotective effect of Spirulina in cerebral ischemia-reperfusion injury in rats,” Journal of Neural Transmission, vol. 117, no. 9, pp. 1083–1091, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Y. Kaynar, M. Hanci, A. Kafadar, K. Gümüştaş, A. Belce, and N. Çiplak, “The effect of duration of compression on lipid peroxidation after experimental spinal cord injury,” Neurosurgical Review, vol. 21, no. 2-3, pp. 117–120, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. D. M. Basso, M. S. Beattie, and J. C. Bresnahan, “A sensitive and reliable locomotor rating scale for open field testing in rats,” Journal of Neurotrauma, vol. 12, no. 1, pp. 1–21, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. C. H. Tator, “Update on the pathophysiology and pathology of acute spinal cord injury,” Brain Pathology, vol. 5, no. 4, pp. 407–413, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Young, “Spinal cord contusion models,” Progress in Brain Research, vol. 137, pp. 231–255, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Khan, R. M. Havey, S. T. Sayers, A. Patwardhan, and W. W. King, “Animal models of spinal cord contusion injuries,” Laboratory Animal Science, vol. 49, no. 2, pp. 161–172, 1999. View at Google Scholar · View at Scopus
  24. M. Lu, Z. Quan, B. Liu, D. Jiang, Y. Ou, and J. Zhao, “Establishment and assessment of the mouse model for spinal cord injury,” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 22, no. 8, pp. 933–938, 2008. View at Google Scholar · View at Scopus
  25. S. Dijkstra, S. Duis, I. M. Pans et al., “Intraspinal administration of an antibody against CD81 enhances functional recovery and tissue sparing after experimental spinal cord injury,” Experimental Neurology, vol. 202, no. 1, pp. 57–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Al Moutaery, C. Morais, N. Biary, S. Al Deeb, and M. Tariq, “Effect of acrylamide on neurological recovery following spinal cord injury in rats,” Acta Neurochirurgica, vol. 141, no. 9, pp. 989–999, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Aslan, M. Cemek, M. E. Buyukokuroglu et al., “Dantrolene can reduce secondary damage after spinal cord injury,” European Spine Journal, vol. 18, no. 10, pp. 1442–1451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Yazihan, K. Uzuner, B. Salman, M. Vural, T. Koken, and A. Arslantas, “Erythropoietin improves oxidative stress following spinal cord trauma in rats,” Injury, vol. 39, no. 12, pp. 1408–1413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. R. Plemel, G. Duncan, K. K. Chen et al., “A graded forceps crush spinal cord injury model in mice,” Journal of Neurotrauma, vol. 25, no. 4, pp. 350–370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Fujiki, Y. Furukawa, H. Kobayashi et al., “Geranylgeranylacetone limits secondary injury, neuronal death, and progressive necrosis and cavitation after spinal cord injury,” Brain Research, vol. 1053, no. 1-2, pp. 175–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. D. M. Basso, M. S. Beattie, and J. C. Bresnahan, “Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection,” Experimental Neurology, vol. 139, no. 2, pp. 244–256, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. A. R. Blight, “Axonal physiology of chronic spinal cord injury in the cat: intracellular recordng in vitro,” Neuroscience, vol. 10, no. 4, pp. 1471–1486, 1983. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Nashmi and M. G. Fehlings, “Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord,” Neuroscience, vol. 104, no. 1, pp. 235–251, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. J. C. Bresnahan, J. S. King, G. F. Martin, and D. Yashon, “A neuroanatomical analysis of spinal cord injury in the rhesus monkey (Macaca mulatta),” Journal of the Neurological Sciences, vol. 28, no. 4, pp. 521–542, 1976. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Guth, C. P. Barrett, E. J. Donati, F. D. Anderson, M. V. Smith, and M. Lifson, “Essentiality of a specific cellular terrain for growth of axons into a spinal cord lesion,” Experimental Neurology, vol. 88, no. 1, pp. 1–12, 1985. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Guth, Z. Zhang, N. A. Diprospero, K. Joubin, and M. T. Fitch, “Spinal cord injury in the rat: treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function,” Experimental Neurology, vol. 126, no. 1, pp. 76–87, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Farooque, J. Isaksson, D. M. Jackson, and Y. Olsson, “Clomethiazole (ZENDRA, CMZ) improves hind limb motor function and reduces neuronal damage after severe spinal cord injury in rat,” Acta Neuropathologica, vol. 98, no. 1, pp. 22–30, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. T. B. Ducker, G. W. Kindt, and L. G. Kempf, “Pathological findings in acute experimental spinal cord trauma.,” Journal of Neurosurgery, vol. 35, no. 6, pp. 700–708, 1971. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Fujiki, Z. Zhang, L. Guth, and O. Steward, “Genetic influences on cellular reactions to spinal cord injury: activation of macrophages/microglia and astrocytes is delayed in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration,” The Journal of Comparative Neurology, vol. 371, no. 3, pp. 469–484, 1996. View at Google Scholar
  40. Z. Zhang, M. Fujiki, L. Guth, and O. Steward, “Genetic influences on ce llular reactions to spinal cord injury: a wound-healing response present in normal mice is impaired in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration,” Journal of Comparative Neurology, vol. 371, no. 3, pp. 485–495, 1996. View at Publisher · View at Google Scholar
  41. Y. Taoka, K. Okajima, M. Uchiba et al., “Role of neutrophils in spinal cord injury in the rat,” Neuroscience, vol. 79, no. 4, pp. 1177–1182, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Hamada, T. Ikata, S. Katoh et al., “Involvement of an intercellular adhesion molecule 1-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats,” Journal of Neurochemistry, vol. 66, no. 4, pp. 1525–1531, 1996. View at Google Scholar · View at Scopus
  43. J. Xu, Z. X. Qu, E. L. Hogan, and P. L. Perot Jr., “Protective effect of methylprednisolone on vascular injury in rat spinal cord injury,” Journal of Neurotrauma, vol. 9, no. 3, pp. 245–253, 1992. View at Publisher · View at Google Scholar · View at Scopus